Atlas Trials

Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid

Clinical trial NCT00987220 · COMPLETED

Trial details

NCT number
NCT00987220
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Alzheimer's DiseaseDementia
Start date
2009-10-01
Primary completion
2010-02-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.